<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00364494</url>
  </required_header>
  <id_info>
    <org_study_id>DS/URC/ER/mm 556/DG</org_study_id>
    <nct_id>NCT00364494</nct_id>
  </id_info>
  <brief_title>Hemodilution and Outcome in Cardiac Surgery</brief_title>
  <official_title>Effect of Moderate Hemodilution During Cardiopulmonary Bypass on Postoperative Outcome Following Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università Vita-Salute San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università Vita-Salute San Raffaele</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An hematocrit of 21-25% is supposed to perform the best organ protection during
      cardiopulmonary bypass for cardiac surgery.

      The investigators want to establish the best timing for a transfusion (in patients with a
      predicted low hematocrit during cardiopulmonary bypass) and the efficacy of preprocedural
      hemodilution (in patients with a predicted high hematocrit during cardiopulmonary bypass) in
      patients undergoing cardiac surgery.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    difficult enrollment after the primary investigator left the centre
  </why_stopped>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>renal function</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>other organ damage</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prolonged mechanical ventilation, Intensive Care Unit (ICU) and hospital stay</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sepsis</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>exitus</measure>
  </secondary_outcome>
  <condition>Kidney Failure</condition>
  <condition>Intraoperative Complications</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Different timing of red blood cells transfusion (substudy 1); Acute hemodilution versus no hemodilution (substudy 2)</intervention_name>
    <description>Subgroup 1,with Ht&lt;21% receive an hemotransfusion before or after CEC;subgroup 2,with Ht&gt;25% bleed or not</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing cardiac surgery

        Exclusion Criteria:

          -  Age &lt; 18 years old

          -  Not signing written consent

          -  Age &lt; 65 years old (subgroup 1)

          -  Emergency, aortic stenosis, main left coronary stenosis (subgroup 2)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Landoni, MD</last_name>
    <role>Study Director</role>
    <affiliation>Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milano, Italia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giuseppe Crescenzi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milano, Italia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Università Vita-Salute San Raffaele, Milano, Italia e Istituto Scientifico San Raffaele, Milano, Italia</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2006</study_first_submitted>
  <study_first_submitted_qc>August 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2006</study_first_posted>
  <last_update_submitted>August 13, 2009</last_update_submitted>
  <last_update_submitted_qc>August 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2009</last_update_posted>
  <keyword>Hematocrit</keyword>
  <keyword>Hemodilution</keyword>
  <keyword>Blood Transfusion</keyword>
  <keyword>Cardiopulmonary Bypass</keyword>
  <keyword>Multiple Organ Failure</keyword>
  <keyword>Surgery, Cardiac</keyword>
  <keyword>Kidney Failure</keyword>
  <keyword>Cardiac Surgical Procedures</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Intraoperative Complications</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

